The goal of the new Structural Biology Core is to provide Lineberger Comprehensive Cancer Center (LCCC) members with access to and training in the state-of-the-art methodologies of structural biology and molecular modeling. Services include high-throughput automated protein and nucleic acid crystallization, x-ray diffraction data collection, crystal structural determination and analysis, solution structure determination by multidimensional nuclear magnetic resonance (NMR) methods, and sequence-informed molecular modeling and molecular dynamics. The Core is led by structural biologist Matthew R. Redinbo, Ph.D., (Molecular Therapeutics) and UNC LCCC member, with individual facilities managed by Ph.D.-level scientists with over 40 collective years of research experience. This new Core adds value to the Center by making available to non-structural biologists the complex methodologies of crystallography, NMR and molecular modeling, with the goal of adding the tools of structural biology to the repertoire used by LCCC researchers across disciplines. Highlights of recent research supported by the Core include: elucidation of the detailed molecular mechanism of Rho GTPase activation by Dbl-family GEFs, and unraveling the structural basis of drug interactions caused by activation of PXR, the primary xenobiotic sensor in humans. Future plans for the Core include additional structural biology capabilities, and increased use by a campus-wide initiative in drug discovery designed to identify drug targets and generate initial clinical candidates.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016086-30
Application #
7100721
Study Section
Subcommittee G - Education (NCI)
Project Start
2004-12-01
Project End
2009-11-30
Budget Start
2004-12-01
Budget End
2005-11-30
Support Year
30
Fiscal Year
2005
Total Cost
$79,554
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Brock, William J; Beaudoin, James J; Slizgi, Jason R et al. (2018) Bile Acids as Potential Biomarkers to Assess Liver Impairment in Polycystic Kidney Disease. Int J Toxicol 37:144-154
Thomas, Nancy E; Edmiston, Sharon N; Tsai, Yihsuan S et al. (2018) Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis. Am J Dermatopathol :
Bensen, Jeannette T; Graff, Mariaelisa; Young, Kristin L et al. (2018) A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women. Breast Cancer Res 20:45
Hall, Marissa G; Marteau, Theresa M; Sunstein, Cass R et al. (2018) Public support for pictorial warnings on cigarette packs: an experimental study of US smokers. J Behav Med 41:398-405
Ma, Shaohua; Paiboonrungruan, Chorlada; Yan, Tiansheng et al. (2018) Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target. Ann N Y Acad Sci 1434:164-172
Aung, Kyaw L; Fischer, Sandra E; Denroche, Robert E et al. (2018) Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial. Clin Cancer Res 24:1344-1354
Suh, Junghyun L; Watts, Brian; Stuckey, Jacob I et al. (2018) Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID Subunit 1. Biochemistry 57:2140-2149
Myung, Ja Hye; Eblan, Michael J; Caster, Joseph M et al. (2018) Multivalent Binding and Biomimetic Cell Rolling Improves the Sensitivity and Specificity of Circulating Tumor Cell Capture. Clin Cancer Res 24:2539-2547
Lindström, Linda S; Yau, Christina; Czene, Kamila et al. (2018) Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer. J Natl Cancer Inst 110:726-733
Jayasinghe, Reyka G; Cao, Song; Gao, Qingsong et al. (2018) Systematic Analysis of Splice-Site-Creating Mutations in Cancer. Cell Rep 23:270-281.e3

Showing the most recent 10 out of 1525 publications